N-tert-Butyl-2-iodobenzamide, 98%, 100mg

Methyl N-(1,1-dioxidotetrahydro-3-thienyl)glycinate hydrochloride, 95.0%, 1g

2-[(dimethylamino)methyl]benzoic acid, 95.0%, 10g

2,3-Benzofuran, 99.0%, 100g

1,4-Diphenoxybenzene, 95.0%, 25g

2-Methoxy-6-oxo-1,6-dihydropyridine-3-carbonitrile, 95.0%, 10g

3-Bromo-5-methylphenol, 98.0%, 500g

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, pour la synthèse peptidique, emballage en verre

4'-Pentyl-[1,1'-biphenyl]-4-carboxylic acid, 95.0%, 1g

2-Amino-3-bromo-5-(trifluoromethyl)benzonitrile, 97.0%, 250mg

2-Bromo-4,5-difluoroanisole, 98.0%, 1g

2-Chlorothiazole-4-carbonitrile, 95.0%, 100mg

4-Aminothiomorpholine 1,1-Dioxide>95.0%(GC)(T)1g